Improving Quality of Life Based on Electronic Patient Reported Outcomes in Patients with CLL and MDS: The Mypal Study
Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), Lydia Scarfò(IRCCS Ospedale San Raffaele), Dimitrios Kyrou(Centre for Research and Technology Hellas), Stephan Kiefer(Fraunhofer Institute for Biomedical Engineering), Christos Demosthenous(G. Papanikolaou General Hospital), Richard Rosenquist(Karolinska University Hospital), Jonathan Reston, Lefteris Koumakis, Tina Garani-Papadatos(University of West Attica), Norbert Graf(Saarland University), Christina Karamanidou(Centre for Research and Technology Hellas), Anastasia Chatzidimitriou(Karolinska Institutet), Pantelis Natsiavas(Centre for Research and Technology Hellas), George Zacharioudakis(Foundation for Research and Technology Hellas), Julie Ling(World Health Organization Regional Office for Europe), Panagiotis Argyropaidas(Foundation for Research and Technology Hellas), Michael Doubek(Central European Institute of Technology), Heather Parker, Κώστας Σταματόπουλος(Centre for Research and Technology Hellas), Annette Sander(Athens Medical Center), Christine Kakalou(Centre for Research and Technology Hellas), Charalampos Pontikoglou(University of Crete), Marcel Meyerheim(Saarland University), Jana Didi(Central European Institute of Technology), Harriet Ryblom(Karolinska University Hospital), Eleni Kazantzaki(University of Crete), Panos Bonotis(Centre for Research and Technology Hellas), Eleni Papadaki(University of Crete), Maria Chatzimina(Mediterranean University), Sheila Payne(Lancaster University), Paolo Ghia(Vita-Salute San Raffaele University), Fatima Schera(Fraunhofer Institute for Biomedical Engineering), Sotiria Besikli‐Dimou(Centre for Research and Technology Hellas), Cathy Payne(European Association for Palliative Care), Karin Ekstroem Smedby(Karolinska Institutet), Maria Vasilopoulou(Centre for Research and Technology Hellas), Stefan Hoffman(Software (Germany)), Niki Stavrogianni(G. Papanikolaou General Hospital), Eva Hellström Lindberg(Karolinska Institutet), Georgios Karakatsoulis(University of Ioannina)
Cited by 0
Related Papers
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
|Arthritis & Rheumatism|2006|888